Ameritas Investment Partners’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.76K | Hold |
2,087
| – | – | ﹤0.01% | 2911 |
|
|
2025
Q4 | $17.1K | Hold |
2,087
| – | – | ﹤0.01% | 2709 |
|
|
2025
Q3 | $15.4K | Hold |
2,087
| – | – | ﹤0.01% | 2792 |
|
|
2025
Q2 | $16.9K | Hold |
2,087
| – | – | ﹤0.01% | 2729 |
|
|
2025
Q1 | $14.7K | Hold |
2,087
| – | – | ﹤0.01% | 2677 |
|
|
2024
Q4 | $15.5K | Hold |
2,087
| – | – | ﹤0.01% | 2739 |
|
|
2024
Q3 | $10.3K | Hold |
2,087
| – | – | ﹤0.01% | 2908 |
|
|
2024
Q2 | $10.7K | Buy |
+2,087
| New | +$12.4K | ﹤0.01% | 2897 |
|
|
2023
Q2 | – | Sell |
-2,282
| Closed | -$8.62K | – | 3166 |
|
|
2023
Q1 | $8.62K | Hold |
2,282
| – | – | ﹤0.01% | 2767 |
|
|
2022
Q4 | $15.4K | Hold |
2,282
| – | – | ﹤0.01% | 2668 |
|
|
2022
Q3 | $20K | Hold |
2,282
| – | – | ﹤0.01% | 2521 |
|
|
2022
Q2 | $22K | Hold |
2,282
| – | – | ﹤0.01% | 2509 |
|
|
2022
Q1 | $26K | Hold |
2,282
| – | – | ﹤0.01% | 2442 |
|
|
2021
Q4 | $25K | Hold |
2,282
| – | – | ﹤0.01% | 2537 |
|
|
2021
Q3 | $21K | Hold |
2,282
| – | – | ﹤0.01% | 2667 |
|
|
2021
Q2 | $26K | Hold |
2,282
| – | – | ﹤0.01% | 2594 |
|
|
2021
Q1 | $24K | Hold |
2,282
| – | – | ﹤0.01% | 2485 |
|
|
2020
Q4 | $25K | Hold |
2,282
| – | – | ﹤0.01% | 2353 |
|
|
2020
Q3 | $22K | Hold |
2,282
| – | – | ﹤0.01% | 2321 |
|
|
2020
Q2 | $18K | Hold |
2,282
| – | – | ﹤0.01% | 2390 |
|
|
2020
Q1 | $20K | Hold |
2,282
| – | – | ﹤0.01% | 2186 |
|
|
2019
Q4 | $26K | Hold |
2,282
| – | – | ﹤0.01% | 2278 |
|
|
2019
Q3 | $25K | Hold |
2,282
| – | – | ﹤0.01% | 2272 |
|
|
2019
Q2 | $21K | Hold |
2,282
| – | – | ﹤0.01% | 2418 |
|
|
2019
Q1 | $28K | Hold |
2,282
| – | – | ﹤0.01% | 2199 |
|
|
2018
Q4 | $27K | Hold |
2,282
| – | – | ﹤0.01% | 2159 |
|
|
2018
Q3 | $33K | Hold |
2,282
| – | – | ﹤0.01% | 2223 |
|
|
2018
Q2 | $34K | Hold |
2,282
| – | – | ﹤0.01% | 2221 |
|
|
2018
Q1 | $30K | Sell |
2,282
-1,305
| -36% | -$17.1K | ﹤0.01% | 2209 |
|
|
2017
Q4 | $49K | Hold |
3,587
| – | – | ﹤0.01% | 1942 |
|
|
2017
Q3 | $45K | Hold |
3,587
| – | – | ﹤0.01% | 1957 |
|
|
2017
Q2 | $53K | Hold |
3,587
| – | – | ﹤0.01% | 1866 |
|
|
2017
Q1 | $42K | Buy |
3,587
+2,282
| +175% | +$28.9K | ﹤0.01% | 1968 |
|
|
2016
Q4 | $18K | Sell |
1,305
-195
| -13% | -$2.7K | ﹤0.01% | 1176 |
|
|
2016
Q3 | $20K | Hold |
1,500
| – | – | ﹤0.01% | 1157 |
|
|
2016
Q2 | $16K | Hold |
1,500
| – | – | ﹤0.01% | 1103 |
|
|
2016
Q1 | $15K | Hold |
1,500
| – | – | ﹤0.01% | 1102 |
|
|
2015
Q4 | $17K | Buy |
+1,500
| New | +$18.4K | ﹤0.01% | 1091 |
|
Other funds holding LFCR
2L
WC
LPAM
GRIM
3C
VCM
GC
Ameritas Investment Partners's LFCR Position: Q1 2026 in Review
Ameritas Investment Partners held its Lifecore Biomedical (LFCR) position steady in Q1 2026 at 2,087 shares worth $7.76K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.
Ameritas Investment Partners first reported a position in LFCR in Q4 2015 and has held it in 38 quarters since. The position peaked at $53K in Q2 2017. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.
- Ameritas Investment Partners held 2,087 shares of Lifecore Biomedical worth $7.76K as of Q1 2026.
- Ameritas Investment Partners left its Lifecore Biomedical share count unchanged in Q1 2026.
- Lifecore Biomedical made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2911 holding.
- Ameritas Investment Partners first reported a position in Lifecore Biomedical in Q4 2015 and has held it in 38 quarters since.
- Ameritas Investment Partners's Lifecore Biomedical position peaked at $53K in Q2 2017.
- 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.